Amir T Fathi, MD, is the Program Director of the Center for Leukemia at the Massachusetts General Hospital Cancer Center; he is also an Associate Professor in Medicine at Harvard Medical School. He is a graduate of Yale University, where he graduated summa cum laude with a Baccalaureate of Science in molecular, cellular, and developmental biology. He went on to receive his medical degree with Honors at the Yale School of Medicine. He also earned a Master's degree in Epidemiology from Harvard School of Public Health. He completed his residency training in internal medicine at Massachusetts General Hospital and fellowships in both hematology and medical oncology at Johns Hopkins Hospital. Dr Fathi is a clinician-scientist with a deep interest in developing novel therapies for acute myeloid leukemia (AML). As faculty at the Massachusetts General Hospital Cancer Center and Harvard Medical School, he provides clinical care, supervises trainees, administers a busy clinic, and as the director of clinical research in leukemia, is the lead investigator on numerous clinical trials investigating novel treatments in acute leukemias.

Dr Fathi's other interests focus on developing translational projects to discover new targets for therapy. He has presented at national meetings of the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH), spoken at national academic and educational meetings, and has served on national committees that establish guidelines for the management of acute and chronic leukemias. Dr Fathi endeavors to provide outstanding clinical care, teaching and mentoring, while also conducting translational projects, retrospective research, and clinical trials, with the overarching goal improving the health and outcomes of patients with bone marrow malignancies.